Mackin James P 4
4 · ARTIVION, INC. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
ARTIVION, INC.AORT
Mackin James P
President & CEO
Transactions
- Sale
Common Stock
2025-03-06$24.76/sh−70,700$1,750,843→ 865,283 total - Award
Common Stock
2025-03-06+115,701→ 878,107 total - Exercise/Conversion
Common Stock
2025-03-06$21.55/sh+75,615$1,629,503→ 935,983 total - Sale
Common Stock
2025-03-06$24.80/sh−17,739$440,005→ 860,368 total - Exercise/Conversion
Stock Options (Right to buy)
2025-03-06−75,615→ 0 totalExercise: $21.55From: 2019-03-12Exp: 2025-03-12→ Common Stock (75,615 underlying)
Footnotes (5)
- [F1]Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date.
- [F2]These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- [F3]The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024.
- [F4]Reflects weighted average price. Range of prices were between $24.40 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.